Latest news
TMCI: Q2 revenue fell 4% but accelerated case growth and new products drove improved outlook - TradingViewTradingView · Fri, 07 Aug 2026 13:28:34 GMTRCAT: Record Q2 revenue, improved margins, and strong H2 outlook with diversified growth - TradingViewTradingView · Thu, 06 Aug 2026 23:46:41 GMTOABI: Revenue growth and clinical progress drove improved outlook and reduced net loss - TradingViewTradingView · Thu, 06 Aug 2026 22:47:01 GMTALTG: Sequential revenue and margin gains, strong backlog, and improved capital efficiency drive outlook - TradingViewTradingView · Thu, 06 Aug 2026 22:31:07 GMTVITL: Q2 revenue fell 10.1%, but retail share rose; H2 outlook improves with cost and supply actions - TradingViewTradingView · Thu, 06 Aug 2026 16:20:49 GMTBKSY: Q2 2026 revenue up 50% year-over-year, with improved margins and reaffirmed full-year outlook - TradingViewTradingView · Thu, 06 Aug 2026 12:27:51 GMTASPN: Q2 2026 saw strong sequential revenue growth and improved outlook despite incident-related costs - TradingViewTradingView · Thu, 06 Aug 2026 11:39:33 GMTKELYA: Q2 revenue declined 5.8% year-over-year, but margin and outlook improved sequentially - TradingViewTradingView · Thu, 06 Aug 2026 11:33:02 GMT